You are here: Home » PTI Stories » National » News
Business Standard

Abbott India Q2 net profit up 23% at Rs 75 cr

Press Trust of India  |  New Delhi 

Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.



Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Abbott India Q2 net profit up 23% at Rs 75 cr

Pharma firm Abbott India today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales. The company had posted a net profit of Rs 61.16 crore in the year-ago period, Abbott India said in a BSE filing. Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago. Abbott India offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. Shares of Abbott India today closed 4.88 per cent higher at Rs 4,925 apiece on BSE. Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.

Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Abbott India Q2 net profit up 23% at Rs 75 cr

Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.

Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22